Indivior Pharmaceuticals, Inc. (INDV)
31.51
-1.01
(-3.11%)
USD |
NASDAQ |
Apr 16, 16:00
31.49
-0.02
(-0.06%)
After-Hours: 20:00
Indivior Pharmaceuticals Free Cash Flow : -94.86M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ANI Pharmaceuticals, Inc. | 150.90M |
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Liquidia Corp. | -40.02M |
| Pulse Biosciences, Inc. | -54.46M |
| Ultragenyx Pharmaceutical, Inc. | -487.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -226.38M |
| Cash from Investing (Quarterly) | -22.46M |
| Cash from Financing (Quarterly) | -5.638M |
| Free Cash Flow Per Share (Quarterly) | -1.999 |
| Free Cash Flow to Equity (Quarterly) | -244.85M |
| Free Cash Flow to Firm (Quarterly) | -242.29M |
| Free Cash Flow Yield | -2.38% |